Friday, April 15, 2016 8:22:33 PM
As for the armor angle, its a wild card that John Bourque may have already set in motion prior to and after his release from prison. As I suggested, it's personal with him and only CJ and Juan would know if advanced arrangements for Kryron armor have already been set in motion, ready to spring forth and surprise even those trusted folks that visited the Lab and were given the impression that armor was only a "work in progress" when it has been "full steam ahead" agenda.
So lets focus on wire, and here we have two avenues for sales, plain Kryron rods, and these newly announced, seasoned with nano graphene, Kryron rods.
So sales in 2016 is a yes or no, it all depends on when samples for testing by "our partner foreign and domestic testing facilities" were submitted, and how long test durations were needed to obtain results.
Understanding "... our partner foreign and domestic testing facilities [will] produce various wire grades for evaluation [of nano graphene Kryron rods] in the production areas of..." seems to say that this process has not yet started, meaning 2017 - 2018 before possible sales.
I'm inclined to think that regular vanilla flavored Kryron rods have already been submitted for testing based on the stated expectations by Bourque Industries expressed in 2011 (5 years ago).
It appears that I didn't take my own advice and jumped the gun in regards to my attitude expressed in: The Market would take serious notice when the mentioned "working together with Bourque Industries manufacturing partners in Casa Grande, Arizona" identifies themselves with a press release about Nano Graph™ (Nano-Graphene Kryron® Metal rods). Addition Market notice would occur if "our partner foreign and domestic testing facilities" were identified.
But then, perhaps I'll get lucky being wrong not to take my own advice.
The posts contained on my (gotmilk) account are my own opinions and are not recommendations or advise to buy or sell any security, stocks or other investments. These posts are for entertainment purposes only and are not considered to be facts or truth.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM